{"entity":{"id":"next-generation-adc-payloads","kind":"term","name":"Next-generation antibody-conjugate payloads","aka":["non-TOP1 payloads","novel ADC payload mechanisms","ADC payload diversification"],"tldr":"Antibodies can carry drugs that block gene reading, remove proteins, interrupt cell signals or activate immune cells. Each approach needs its own evidence that the drug reaches its target and helps people safely.","summary":"Payload diversification changes what an antibody delivers, independently of which surface antigen it binds. This map includes transcription and splicing inhibitors, repair-checkpoint inhibitors, metabolic and apoptosis agents, targeted protein degraders, immune agonists, signaling inhibitors, and additional tubulin and DNA-interacting scaffolds. Bispecific targeting is a delivery format; dual payload means distinct agents on one construct. Neither label alone establishes a new payload mechanism. Protein toxins, radionuclides, oligonucleotides, photosensitizers and antibody-directed nanocarriers have related delivery questions but retain their own format definitions. Evidence ranges from cell experiments and animal models to early clinical studies; a mechanism change does not by itself establish benefit after a TOP1 antibody-drug conjugate.","asOf":"2026-11-09","links":[{"label":"Dolaflexin: AF-HPA and auristatin F in preclinical models (2021)","url":"https://pubmed.ncbi.nlm.nih.gov/33722857/"},{"label":"XMT-1536 preclinical composition and NaPi2b-directed models (2021)","url":"https://pubmed.ncbi.nlm.nih.gov/33722858/"},{"label":"IMGC936 with DM21-C: preclinical studies (2022)","url":"https://pubmed.ncbi.nlm.nih.gov/35511740/"},{"label":"Yamazaki et al., dual-payload conjugates in breast cancer models (2021)","url":"https://doi.org/10.1038/s41467-021-23793-7"},{"label":"Carlino et al., Gq/11 inhibitor conjugate phase 1 study (2026)","url":"https://doi.org/10.1038/s41591-026-04518-z"}],"tags":[],"related":["af-hpa","dm21-c-maytansinoid-system","transcription-inhibitor-payloads","amanitin-payloads","triptolide-payloads","spliceosome-inhibitor-payloads","cdk-inhibitor-payloads","ddr-inhibitor-payloads","atr-inhibitor-payloads","nampt-inhibitor-payloads","bcl-xl-inhibitor-payloads","mcl1-inhibitor-payloads","hdac-inhibitor-payloads","gspt1-degrader-payloads","brd4-degrader-payloads","kif11-degrader-payloads","ksp-inhibitor-payloads","sting-agonist-payloads","tlr-agonist-payloads","gq11-inhibitor-payloads","pi3k-pikk-inhibitor-payloads","tubulysin-payloads","hemiasterlin-payloads","eribulin-payload","cryptophycin-payloads","anthracycline-payloads","ign-payloads","pdd-payloads","protein-alkylator-payloads","proteasome-inhibitor-payloads","ferroptosis-conjugate-payloads","protein-toxin-payloads"],"cancers":[],"sections":[],"technologies":["adc","dual-payload-adc","bispecific-adc","degrader-antibody-conjugate","immune-stimulating-adc","radioimmunotherapy","antibody-oligonucleotide-conjugates","photoimmunotherapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["payload"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["This is a map of publicly described mechanisms, not an exhaustive list of proprietary payload molecules or a ranking of treatments. Follow each concept to the experiment or trial supporting it.","Chemical redesign also matters within an existing mechanism. The Dolaflexin studies distinguish AF-HPA from its active auristatin F metabolite. The IMGC936 preclinical report describes a peptide-linked DM21-C maytansinoid system. These are distinct cargo designs within the tubulin category, rather than proof that every redesign introduces a new mechanism or avoids clinical resistance."],"category":"ADC chemistry"},"route":"/terms/next-generation-adc-payloads/","neighbours":{"term":[{"id":"af-hpa","kind":"term","name":"AF-HPA and auristatin F","route":"/terms/af-hpa/"},{"id":"amanitin-payloads","kind":"term","name":"Amanitin payloads","route":"/terms/amanitin-payloads/"},{"id":"anthracycline-payloads","kind":"term","name":"Anthracycline payloads","route":"/terms/anthracycline-payloads/"},{"id":"atr-inhibitor-payloads","kind":"term","name":"ATR inhibitor payloads","route":"/terms/atr-inhibitor-payloads/"},{"id":"bcl-xl-inhibitor-payloads","kind":"term","name":"BCL-XL inhibitor payloads","route":"/terms/bcl-xl-inhibitor-payloads/"},{"id":"brd4-degrader-payloads","kind":"term","name":"BRD4 degrader payloads","route":"/terms/brd4-degrader-payloads/"},{"id":"cryptophycin-payloads","kind":"term","name":"Cryptophycin payloads","route":"/terms/cryptophycin-payloads/"},{"id":"cdk-inhibitor-payloads","kind":"term","name":"Cyclin-dependent kinase inhibitor payloads","route":"/terms/cdk-inhibitor-payloads/"},{"id":"dm21-c-maytansinoid-system","kind":"term","name":"DM21-C peptide-linked maytansinoid system","route":"/terms/dm21-c-maytansinoid-system/"},{"id":"ddr-inhibitor-payloads","kind":"term","name":"DNA damage response inhibitor payloads","route":"/terms/ddr-inhibitor-payloads/"},{"id":"eribulin-payload","kind":"term","name":"Eribulin as an antibody-conjugate payload","route":"/terms/eribulin-payload/"},{"id":"ferroptosis-conjugate-payloads","kind":"term","name":"Ferroptosis-inducing payloads and antibody-directed carriers","route":"/terms/ferroptosis-conjugate-payloads/"},{"id":"gq11-inhibitor-payloads","kind":"term","name":"Gq/11 inhibitor payloads","route":"/terms/gq11-inhibitor-payloads/"},{"id":"gspt1-degrader-payloads","kind":"term","name":"GSPT1 degrader payloads","route":"/terms/gspt1-degrader-payloads/"},{"id":"hemiasterlin-payloads","kind":"term","name":"Hemiasterlin payloads","route":"/terms/hemiasterlin-payloads/"},{"id":"hdac-inhibitor-payloads","kind":"term","name":"Histone deacetylase inhibitor payloads","route":"/terms/hdac-inhibitor-payloads/"},{"id":"ign-payloads","kind":"term","name":"Indolinobenzodiazepine payloads","route":"/terms/ign-payloads/"},{"id":"kif11-degrader-payloads","kind":"term","name":"KIF11 degrader payloads","route":"/terms/kif11-degrader-payloads/"},{"id":"ksp-inhibitor-payloads","kind":"term","name":"Kinesin spindle protein inhibitor payloads","route":"/terms/ksp-inhibitor-payloads/"},{"id":"mcl1-inhibitor-payloads","kind":"term","name":"MCL-1 inhibitor payloads","route":"/terms/mcl1-inhibitor-payloads/"},{"id":"nampt-inhibitor-payloads","kind":"term","name":"NAMPT inhibitor payloads","route":"/terms/nampt-inhibitor-payloads/"},{"id":"payload","kind":"term","name":"Payload (ADC)","route":"/terms/payload/"},{"id":"pi3k-pikk-inhibitor-payloads","kind":"term","name":"PI3K/PIKK inhibitor payloads","route":"/terms/pi3k-pikk-inhibitor-payloads/"},{"id":"proteasome-inhibitor-payloads","kind":"term","name":"Proteasome inhibitor payloads","route":"/terms/proteasome-inhibitor-payloads/"},{"id":"protein-toxin-payloads","kind":"term","name":"Protein toxin payloads and immunotoxins","route":"/terms/protein-toxin-payloads/"},{"id":"protein-alkylator-payloads","kind":"term","name":"Protein-alkylating payloads","route":"/terms/protein-alkylator-payloads/"},{"id":"pdd-payloads","kind":"term","name":"Pyridinobenzodiazepine payloads","route":"/terms/pdd-payloads/"},{"id":"spliceosome-inhibitor-payloads","kind":"term","name":"Spliceosome-inhibitor payloads","route":"/terms/spliceosome-inhibitor-payloads/"},{"id":"sting-agonist-payloads","kind":"term","name":"STING agonist payloads","route":"/terms/sting-agonist-payloads/"},{"id":"tlr-agonist-payloads","kind":"term","name":"Toll-like receptor agonist payloads","route":"/terms/tlr-agonist-payloads/"},{"id":"transcription-inhibitor-payloads","kind":"term","name":"Transcription-inhibitor payloads","route":"/terms/transcription-inhibitor-payloads/"},{"id":"triptolide-payloads","kind":"term","name":"Triptolide payloads","route":"/terms/triptolide-payloads/"},{"id":"tubulysin-payloads","kind":"term","name":"Tubulysin payloads","route":"/terms/tubulysin-payloads/"}],"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"},{"id":"antibody-oligonucleotide-conjugates","kind":"technology","name":"Antibody-oligonucleotide conjugates","route":"/technologies/antibody-oligonucleotide-conjugates/"},{"id":"bispecific-adc","kind":"technology","name":"Bispecific ADC","route":"/technologies/bispecific-adc/"},{"id":"degrader-antibody-conjugate","kind":"technology","name":"Degrader-antibody conjugate (DAC)","route":"/technologies/degrader-antibody-conjugate/"},{"id":"dual-payload-adc","kind":"technology","name":"Dual-payload ADC","route":"/technologies/dual-payload-adc/"},{"id":"immune-stimulating-adc","kind":"technology","name":"Immune-stimulating antibody conjugate (ISAC)","route":"/technologies/immune-stimulating-adc/"},{"id":"photoimmunotherapy","kind":"technology","name":"Photoimmunotherapy & photodynamic therapy","route":"/technologies/photoimmunotherapy/"},{"id":"radioimmunotherapy","kind":"technology","name":"Radio-antibody & radio-ADC","route":"/technologies/radioimmunotherapy/"}]}}